Powered by

Atlas Venture Launches Generation Bio

Jan 04, 2018 - Business Wire

Atlas Venture , a leading biotech venture capital firm,today announced the launch of Generation Bio , a company developing the first genetic medicines that can be titrated to effect and re-dosed for a lifetime of benefit. Atlas founded the company in 2016 with a $25 million Series A.

Generation Bio is developing a breakthrough class of genetic medicines based on its proprietary GeneWave technology, which delivers high levels of durable gene expression and can be re-dosed to titrate and sus...